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Thoracic aortic aneurysm (TAA) is a disease with a high mortality. If not treated,complications include rupture and dissection of the thoracic aorta. TAA is oftenasymptomatic and it can be diagnosed incidentally when imaging studies are carried outfor other reasons. Estimated prevalence of TAA is 0.16-0.34%. It has been reported thatthe prevalence of intracranial aneurysms (IA) in patients with TAA is 9 %. The aim ofthis study was to examine whether the prevalence of thoracic aortic dilatations andaneurysms is higher in patients with ruptured or unruptured IA.
This was a retrospective cohort study. Medical records of 519 patients diagnosed withruptured or unruptured IA at the University Hospital of Turku between 2006 and 2016were reviewed. Diameters of aorta were measured at three points using reference valuesby American College of Radiology. Number, shape, diameter and location of IAs weredetermined.
From 519 patients 94.6% had saccular and 5.4% had fusiform IA.41.6% had ruptured and56.4% unruptured IA. Thoracic aortic dilatation (TAD) was found in 17% and TAA in6% of patients with saccular IA. 64.2% of the dilatations occurred in the aortic arch.Patients with fusiform IA had a prevalence of 29% for TAD and 18% for TAA. It wasfound that higher age, rheumatoid disease and excessive alcohol consumption wereassociated with higher prevalence of TAD and TAA.
According to our study the prevalence of TAD and TAA in patients with IA is higher thanprevious reports of general population state. Our results suggest that the prevalence ofTAD and TAA is higher in patients with saccular IA and a history of rheumatoid diseaseand/or excessive alcohol consumption. Also patients with fusiform IA had a higherprevalence of TAD and TAA.
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Abstract
Background and aims: Prevalence of intracranial aneurysms (IA) is higher in patients with aortic
aneurysms. However, there are lack of studies investigating prevalence of thoracic aortic aneurysms
(TAA)  in  patients  with  intracranial  aneurysms.  The  objective  of  this  study  was  to  evaluate  the
prevalence and risk factors for thoracic aortic dilatations (TAD) and TAAs in patients with IAs.
Methods: We retrospectively reviewed data of 1777 patients with diagnosed IAs at our institution
between 2006 and 2016. We included 413 patients with saccular IAs and available imaging studies
(computed tomography, magnetic resonance imaging or catheter angiography) of all thoracic aortic
segments. TAD was defined according to age- and sex-matched normograms, and TAA as diameter
>4.0 cm.
Results: A total of 85 patients (21%) had TAD or TAA. The prevalence of TADs and TAAs were
18% (n=76) and 8% (n=32) without significant difference between unruptured and ruptured IAs
(p=0.7). Of the 76 patients with TAD, 24 patients (32%) had multiple TADs and 64% of the TADs
located in the aortic arch. Higher age (OR 1.04; p=0.006), rheumatoid disease (OR 4.73; p =0.009)
and alcohol abuse (OR 4.77; p = 0.01) were significant risk factors for TAD/TAA.
Conclusions:  The  prevalence  of  TADs  and  TAAs  is  considerably  higher  in  patients  with  IAs
compared to the reports from the general population, suggesting that IAs might be associated with
aortopathy. Especially IA patients with a history of rheumatoid disease and/or alcohol abuse have a
high risk for TADs/TAAs.
Keywords: Thoracic aortic aneurysms; Thoracic aortic dilatations; intracranial aneurysms;
rheumatoid disease; alcohol abuse
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Introduction
Thoracic aortic aneurysms (TAA) are a potentially fatal disease whose complications have high
mortality; 94–100% for rupture 1, 2 and 55% for acute aortic dissection.3 TAA is typically defined as
a segmental dilatation of ≥50% compared to normal diameter4 or any dilatation above 40 mm.5 The
prevalence of asymptomatic TAA has been measured in 0.16–0.34%.6, 7 Incidentally noted ascending
aortic dilatation (4–5 cm) has been reported in 2.7% of general population.8 Early diagnosis of TAA
is difficult because 95% of patients with TAA are asymptomatic before complications. 9
Aortic aneurysms and intracranial aneurysms (IA) share similar comorbidities and genetic risk
factors,10 and about 10% of patients with TAA also have intracranial aneurysms. 11, 12 One prior study
reported prevalence of ascending TAA of 4.7% in patients with intracranial aneurysms.13 However,
larger studies evaluating the entire thoracic aorta in the patients with IA are not available.
The objective of this study was to evaluate the prevalence and risk factors for TADs and TAAs in
patients with saccular IAs.
Materials and methods
This study was approved by the local institutional review board. Patient consent was not required
because of the retrospective study design.
Study Subjects
We reviewed retrospectively records for 1777 patients diagnosed with ruptured or unruptured IAs at
our institution between 2006 and 2016. Among them, we included 413 patients with saccular IAs and
available contrast-enhanced Computed Tomography Angiography (CT-angiography), unenhanced
CT, Magnetic Resonance Imaging (MRI) or catheter angiography with sufficient coverage of the all
three thoracic aortic segments (ascending thoracic aorta, aortic arch and descending thoracic aorta).
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Among the 413 patients, we also identified 133 patients with echocardiogram to evaluate bicuspid
valve by report. Thoracic aortic dimensions were evaluated by two authors. About 40 cases per each
reviewer were also examined by a board-certified radiologist from our study group to ensure
reliability of measurements.
Thoracic aortic dimensions were measured perpendicular to the axis of blood flow at three points; 1.
mid-ascending aorta, 2. mid-descending aorta at the level of pulmonary artery bifurcation, and 3.
aortic arch at the level of maximum diameter (Supplemental Figure 1). Thoracic aorta was also
evaluated for coarctations from imaging studies and from medical charts.
Gender/age matched and site-specific cut-off values for thoracic aortic dilatation and aneurysms were
used from the study of American College of Radiology14 (Supplemental Table 1). Aortic dilatation
was defined as + 2 SD from normal reference value and aneurysm as diameter of >4.0 cm.
Characteristic of IAs were evaluated from digital subtraction angiography, CTA and MRA images.
In patients with multiple IAs, characteristics were evaluated for ruptured or for largest unruptured IA.
Maximum diameter was measured for dome height and width, and aneurysm neck. Dome to neck
ratio (maximum dome width/maximum neck width) was calculated for each patient. IAs with
daughter sacs or protrusions were defined irregular. IA location was categorized as follows; internal
carotid artery, middle cerebral artery, anterior cerebral artery, and posterior circulation arteries.
Data from patient records were collected at the time intracranial aneurysm were first diagnosed
including age, gender, smoking, alcohol consumption, hypertension, history of intracranial and aortic
aneurysms in first degree relatives, diabetes, history of Turner syndrome, connective tissue disorders
(Marfan syndrome, Ehler-Danlos syndrome type IV, Loyes-Dietz syndrome), rheumatoid diseases
(rheumatoid arthritis, psoriatic arthritis, Sjögren's syndrome, polymyalgia rheumatica, scleroderma,
spondyloarthritis, systemic lupus erythematosus) and vasculitis (Takayasu arteritis, Kawasaki
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disease, Giant cell arteritis, Polyarteritis nodosa, Churg-Strauss syndrome, Henoch-Schönlein
purpura, Bechet’s disease) and peripheral arterial disease.
Alcohol abuse was defined as ≥288 g ethanol per week in men and ≥192 g in women or if patient was
diagnosed with alcoholism (International Statistical Classification of Diseases and Related Health
Problem, diagnosis code F10.2). Diabetes was defined as diabetes requiring per-oral medication or
insulin.  Dyslipidemia  was  defined  as  those  with  LDL cholesterol  ≥3.0  mmol/l  or  total  cholesterol
≥5.0 mmol/l.
Statistical analysis
Statistical  analysis  was  performed by  using  IBM SPSS statistics  23  for  Windows (IBM,  Armonk,
New York). Interclass correlation (ICC), proposed by Shrout and Fleiss,15 was used to assess the
inter-rater reliability (IRR) of imaging measurements. According to Meyer’s study,16 the following
scale for ICC were used to determine the IRR: poor (<0.7), fair (0.7–0.8), good (0.8–0.9), and high
(≥0.9).
Between group differences were evaluated with Chi Square or Fisher's exact test for proportions and
an independent samples T-test for continuous variables and binary logistic regression. Continuous
variables are reported either as mean and standard deviation or as median and interquartile range as
appropriate. Multivariable binary regression was performed by including variables with a p<0.10 in
a model with backward selection (Wald), p-values of <0.05 were considered statistically significant.
Multiple imputation was used for missing data.
Results
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From 1777 patients with diagnosed IA, a total of 413 patients with saccular IA and available imaging
of entire thoracic aorta were included (Figure 1). Available imaging modalities of thoracic aorta are
represented in the Flow chart (Figure 1).  No patients  had  a  history  of  connective  tissue  disorders
(Marfan syndrome, Ehlers-Danlos syndrome and Loeys-Dietz syndrome), Turner syndrome or
vasculitis. Baseline characteristics with normal and abnormally dilated aorta (TAD or TAA) are
presented in Table 1. Of the 23 patients with rheumatoid disease, 15 patients had rheumatoid arthritis,
five patients polymyalgia rheumatica, two patients psoriatic arthritis and one patient Sjögren’s
syndrome.
A  total  of  101  TADs  and  34  TAAs  were  found  in  76  (PR  18.4%)  and  32  (PR  7.7%)  patients.
Altogether 85 patients (20.6%) had TAD or TAA. Multiple TADs were noted in 24 of 76 patients
(31.6%) and multiple TAAs in 2 of 32 patients (6.3%) (Figure 2). Altogether 21 patients had TAD
in two aortic segments and three patients in all three aortic segments. Among 101 TADs, 65 (64.4%)
TADs located in the aortic arch. From 133 patients with available echocardiogram, 2 patients (PR
1.5%) had BAV, but no concurrent TAD or TAA. In one patient, thoracic aortic coarctation was
operated previously in childhood, in same patient TAD was found in descending thoracic aorta.
In a multivariable binary regression model (Figure 3 ), rheumatic disease (OR 4.73; 95% CI, 1.47–
15.2, p=0.009), alcohol abuse (OR 4.77; 95% CI, 1.38–16.5, p= 0.01) and higher age (OR 1.04; 95%




Both raters had good to high reliability of aortic measurements as assesses against those by a board-
certified radiologist (ICC values of 0.91, 0.82, and 0.87 by T.F.; and 0.89, 0.81, and 0.84 by E.P. for
ascending aorta, aortic arch, and descending aorta, respectively)
Discussion
We found that the prevalence of thoracic aortic dilatations and aneurysms is significantly higher in
patients with intracranial aneurysms than in the general population based on earlier reports. As the
threshold of +2SD essentially represents the 95% confidence interval, the prevalence of dilatations in
the current study was almost 9-fold to the expected prevalence. We also found that IA patients with
rheumatoid disease and high alcohol consumption are at a significantly higher risk of having thoracic
aortic dilatations. Interestingly, 64.4% of the dilatations located in the aortic arch and 32% of patients
with  TAD  had  multiple  TADs.  To  our  knowledge,  our  study  is  the  largest  to  date  to  assess  the
association of thoracic aortic dilatations and saccular IAs and to include all three thoracic aortic
segments (aortic arch, ascending and descending aorta) with contemporary diagnostic imaging
modalities.9
Prevalence of TADs and TAAs
In  the  current  study,  the  prevalence  of  abnormally  dilated  aorta  (TAD  or  TAA)  was  20.6%.  The
prevalence of TADs and TAAs was 18.4% and 7.7% respectively. Goyal et al. 2015 study reported
TAA prevalence of 4.7% in patients with IA. This difference may best be explained by the current
study measuring all three thoracic aortic segments, while Goyal et al. 2016 were only measuring the
ascending aorta.13 Although the studies used for reference values were different, the thresholds for
were very similar; accordingly, the rate of ascending aortic dilatation was virtually identical between
the current study and the previous report.
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In the Kuzmik et al. 2010 study, patients with TAA had a 9% prevalence of IAs and prevalence of
IAs were higher when the descending aorta was aneurysmatic (33%) compared to the ascending aorta
(7.1 %).11 In their study only patients with operated TAA were included, possibly neglecting smaller
thoracic aneurysms and dilatations. In addition, they did not describe aortic arch aneurysms
separately. We found that nearly two-third of TADs located in the aortic arch, which is an unusual
location for a TAA – typically aortic arch aneurysms account for approximately 10% of all thoracic
aortic aneurysms.17 Natural history of aortic arch aneurysms is poorly understood, but these patients
have usually high age and burden of comorbidities.18 Nearly half of patients with Turner syndrome
have elongation in aortic arch,19 but since no patients had Turner syndrome in our study, this do not
explain high prevalence of aortic arch TADs. Multiple aortic lesions are usually related to aortic arch
aneurysms,20 which can explain high prevalence of multiple TADs in our study.
Finally, although BAVs are related to concomitant TAAs21 and increased prevalence (PR 7.7%–
9.8%) of IAs,22, 23 only 2 patients (PR 1.5%) had BAV in our study without concomitant TADs or
TAAs. BAV prevalence of 1.5% is comparable to normal population24 and in line with previous
studies which have evaluated prevalence of BAVs in patients with IAs. 13
Risk factors for TAAs and TADs
TAAs and IAs shares similar risk factors, for instance connective tissue diseases such as Marfan’s
Syndrome, Ehler-Danlos Syndrome type IV and Loeys-Dietz syndrome,9, 25 and habitual risk factors
such as smoking and hypertension.9, 26   Saccular IAs, TAAs and abdominal aortic aneurysms share
a similar genetic background10 and approximately 20% of TAA patients have at least one first degree
relative with an arterial aneurysm.27  Our results, however, suggest that smoking, hypertension or a
positive family history of intracranial aneurysms is not an additional risk factor for TAAs or TADs.
In addition, none of the patients in this study had a diagnosis of connective tissue disease, which is
inconsistent with the high prevalence of TAD and TAA in our study. The absence of traditional risk
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factors for aneurysms, presence of multiple thoracic aortic dilatations and the abnormally high
proportion of dilatations in the aortic arch in our study suggests that there could be a hitherto unknown
risk factor, genetic or acquired, shared between IAs and TAAs.
Instead, we found that rheumatoid diseases and excessive alcohol consumption are major risk factors
for concomitant TAD/TAA in patients with saccular IA. There is a lack of studies related to major
alcohol consumption as a risk factor for thoracic aortic aneurysms. These studies have exclusively
focused on abdominal aortic aneurysms with contradictory results; some studies have found alcohol
consumption to decrease28 and others to increase29 the risk for abdominal aortic aneurysms. Shovman
et al. 2016 reported rheumatoid arthritis as a risk factor for TAA with an OR of 1.4 in the general
population.30 In the present study, the risk of TAD was 3-fold for patients with rheumatoid disease in
a population with an overall prevalence of TAD almost a hundred times greater than reported for the
general population. We defined rheumatoid disease beyond only rheumatoid arthritis to include other
autoimmune entities which can explain this difference, although 61% categorized as having
rheumatoid disease indeed had rheumatoid arthritis. Autoimmune diseases can present with aortitis,
which can consequently lead to aortic aneurysm formation.31 The relationship between rheumatoid
diseases and intracranial aneurysm formation has not been described previously, although
autoimmune diseases might be associated with an increased risk of subarachnoid hemorrhage.32
However, in accordance with previous study,13 we did not find differences in the presentation of TAA
or TAD between ruptured and unruptured IAs.
Limitations
This was largest study to this day to evaluate the entire thoracic aorta in patients with IA. Only patients
with widely accepted imaging modalities for TAA diagnosis were included. Because of the
retrospective nature of the study, one of the limitations was potential selection bias, especially in
patients with unruptured IA. In our institution, CT-angiography is usually performed to the level of
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pulmonary artery during the initial diagnosis of subarachnoid hemorrhage. However, in patients with
unruptured IA, chest imaging could have been performed for more various reasons. Another potential
limitation is a lack of a control group of ethnically Finnish patients with measured thoracic aortic
diameters and without IA, which may introduce sampling bias. We did, nonetheless, use normative
reference values from a previous large study with patients of Caucasian ethnicity. Finally, we defined
TAA as a dilatation of >4.0 cm which can overestimate the prevalence of TAA in our population.
However, the exact threshold diameter for a dilatation to be categorized as an aneurysm is not entirely
clear from the existing literature.
Conclusion
The prevalence of thoracic aortic aneurysms and dilatations is higher in patients with intracranial
saccular aneurysms and especially in patients with a history of rheumatoid disease and/or alcohol
abuse. Our results suggest that intracranial aneurysms and thoracic aortic aneurysms/dilatations could
share a similar specific pathogenetic background beyond traditional risk factors such as smoking and
hypertension.
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Figure legends
Figure 1. Flow chart
Abbreviations: TAD, thoracic aortic dilatation; TAA, thoracic aortic aneurysm; BAV, bicuspid aortic
valve.
Figure 2. Prevalence of thoracic aortic dilatations (TAD) and aneurysms (TAA) in patients with
intracranial aneurysms.
Figure 3. Predictors of thoracic aortic dilatations or aneurysms.
Abbreviations: SAH, subarachnoid hemorrhage.
